Navigation Links
New potential therapeutic target discovered for genetic disorder -- Barth syndrome
Date:3/2/2009

Researchers at NYU Langone Medical Center may have discovered a new targeted intervention for Barth Syndrome (BTHS). BTHS, a sometimes fatal disease, is a serious genetic disorder occurring predominantly in males that leads to infection or heart failure in childhood. The new study entitled, "Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome", was recently published in the Proceedings of the National Academy of Sciences, shows the benefits of targeted intervention with an iPLA2-VIA inhibitor that prevents a major symptom of the disease- cardiolipin deficiency.

"Our research has established a causal role of cardiolipin deficiency in the pathogenesis of Barth syndrome and identified an important enzyme in cardiolipin degradation called iPLA2-VIA as a potential target for therapeutic intervention of the disease," said Mindong Ren, Ph.D., lead investigator of the study and assistant professor of cell biology at NYU Langone Medical Center.

BTHS syndrome is an X-linked genetic cardioskeletal muscle disease resulting in muscle weakness and fatigue in patients. The debilitating disorder is caused by a mutation in the genetic coding of tafazzin, an enzyme of the cardiolipin pathway. Cardiolipin is an essential lipid in the inner membrane of mitochondria responsible for normal cell structure and energy production. BTHS patients exhibit defects in cardiolipin metabolism which help fight infections. The various symptoms of BTHS, in addition to cardiolipin deficiency, include cardiomyopathy (weakness in heart muscle), neutropenia (a reduction in neutrophils or white blood cells that fight bacterial infections), muscle weakness & fatigue (caused by cellular deficiency), growth delay, and increase of organic acids in urine.

In a previous study, NYU researchers documented the characteristics of a tafazzin-deficiency in a Drosophila (fruit fly) model of the disease, showing low and abnormal cardiolipin concent
'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3753
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Plasminogen activator inhibitor type-1 -- a potential link between heart failure and diabetes
2. Tiny tool to control growing blood vessels opens new potential in tumor research
3. High CO2 boosts plant respiration, potentially affecting climate and crops
4. Potential new herpes therapy studied
5. Research finds new cause of ozone wheezing and potential treatments
6. LSUSHC researchers find potential new target for hypertension treatment
7. Genome sequence shows sorghums immense potential
8. Researchers identify potential new weapon in battle against HIV infection
9. Potential therapy for congenital muscular dystrophy
10. UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology
11. Pitt researchers create non-toxic clean-up method for potentially toxic nano materials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... FORT BELVOIR, Va. , Dec. 15, 2014 ... its efforts to make it easier to detect ... supply chain. Today the agency started ... marking. The capability will validate the authenticity of ... supply chain. The new quality control measures will ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... /PRNewswire/ -- SailPoint today ... Software that allows BMC to directly distribute ... been tightly integrated with BMC,s Business Service Management ... to the industry,s leading identity GRC solution, helping ...
... studying human reproduction have identified what is likely ... increase in aneuploidy, the term for an abnormal ... Using naturally aging mouse models, researchers showed that ... likely caused by weakened chromosome cohesion. Older ...
... the scientific journal , Osteoporosis International , introduces a ... the current and future burden of postmenopausal osteoporosis in ... researchers from the UK on behalf of the International ... validated using Swedish data. It can be used to ...
Cached Biology News:SailPoint Signs International Reseller Agreement with BMC Software 2SailPoint Signs International Reseller Agreement with BMC Software 3Why the biological clock? Penn study says aging reduces centromere cohesion, disrupts reproduction 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... MILFORD, Mass., May 11, 2011 SeraCare Life Sciences, ... sciences company providing vital products and services to facilitate ... therapeutics, today announced the election of Joseph Nemmers and ... announced that Mr. Nemmers has been appointed to the ...
... Reportlinker.com announces that a new market research ... Healthcare Information Technology ... HIGHLIGHTS * BCC estimates the ... covered in this report at more than $6.3 ...
... DIEGO, May 11, 2011 OncoSec Medical Inc. ... medical approaches to treat solid tumor cancers that ... of three members to its leadership team. Formed ... II clinical trials for its tumor-destroying, tissue-sparing ElectroOncology ...
Cached Biology Technology:SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 2SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 3SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 4Reportlinker Adds Healthcare Information Technology 2Reportlinker Adds Healthcare Information Technology 3Reportlinker Adds Healthcare Information Technology 4Reportlinker Adds Healthcare Information Technology 5Reportlinker Adds Healthcare Information Technology 6Reportlinker Adds Healthcare Information Technology 7Reportlinker Adds Healthcare Information Technology 8Reportlinker Adds Healthcare Information Technology 9Reportlinker Adds Healthcare Information Technology 10Reportlinker Adds Healthcare Information Technology 11OncoSec Announces Leadership Team Appointments 2OncoSec Announces Leadership Team Appointments 3OncoSec Announces Leadership Team Appointments 4
... utility and flexibility press-to-seal silicone isolators can ... the researcher. They are available either pre-cut ... material that can be easily trimmed to ... and non-cytotoxic and can be used to ...
Request Info...
... turntable. Provides up to 30 minutes of walkaway time. Automatic Calibration. Five minute ... RS-232 port. ... ... ...
... • Holds 0.1 mL - 25 mL pipets ... pipets. Also accommodates most standard square or round pipet ... Has four compartments, each 76 mm W x 76 ... x 11 3/8 ins.). Overall dimensions: 89 mm W ...
Biology Products: